SEVERANCE AGREEMENTSeverance Agreement • December 19th, 2014 • Aduro Biotech, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 19th, 2014 Company Industry JurisdictionThis Severance Agreement (the “Agreement”) is entered into by and between Thomas Dubensky (“you” or “your”) and the Company. This Agreement has an effective date of July 31, 2014 (the “Effective Date”). The Board has authorized the Company to enter into this Agreement in order for you to become a Covered Employee (as defined in the Plan) and participant in the Plan as provided by the Plan. This Agreement is the Severance Agreement described in the Plan and this Agreement enumerates the Plan benefits that may be provided to you as a Covered Employee as referenced in Section II of the Plan. All provisions of this Agreement are subject to and governed by the terms of the Plan. In the event of any conflict in terms between the Plan and this Agreement, the terms of the Plan shall prevail and govern.
BANCROFT WAY, LLC Third Addendum to Office and Lab LeaseOffice Lease • December 19th, 2014 • Aduro Biotech, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 19th, 2014 Company Industry JurisdictionTHIS THIRD ADDENDUM TO OFFICE LEASE (the “Third Addendum”) is made and entered into as of April 28, 2014, by and between BANCROFT WAY, LLC, a California limited liability company (“Landlord”) and ADURO BIOTECH, INC., a Delaware corporation (“Tenant”).
ADURO BIOTECH STOCK INCENTIVE PLAN STOCK OPTION AGREEMENTStock Incentive Plan • December 19th, 2014 • Aduro Biotech, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 19th, 2014 Company Industry Jurisdiction